A team of Rochester scientists worked together to protect students who were the most vulnerable to COVID-19 from the virus, as well as to keep staff healthy and schools open.
In April 2020, as COVID wreaked havoc across the globe, the University received a new designation from the National Institutes of Health (NIH). It became one of about a dozen Intellectual and Developmental Disabilities Research Centers (IDDRC) in the country.
This designation strengthened the long-standing relationship between the neuroscience community at the University and the Mary Cariola Center. A year into the pandemic, when the NIH was looking to understand how COVID was spreading in the IDD population, the UR-IDDRC and Mary Cariola took on a $4 million project, funded by the NIH Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) program.
“Many children with an IDD have social communication deficits, speech, and complex health or medical issues,” says John Foxe, director of the Del Monte Institute for Neuroscience, co-director of the UR-IDDRC, and co-principal investigator of the RADx-UP study. “These students need intensive sensory interaction, intervention, and as much socialization and social interaction as we can give them. They need to be in school.”
Isolating persons with positive tests and knowing antibody levels within the Mary Cariola Center community helped keep the virus at bay. Vaccinations were not given or required in this research project, but antibody levels—from vaccinations and illness—were collected and considered as the school reacted to an ever-changing environment.
“We could see how the immunity progressed and changed in both vaccinated and unvaccinated people within the study,” says Martin Zand, co-director of the Clinical & Translational Science Institute and co-principal investigator of the RADx-UP project, who leads this aspect of the research, including collecting the samples at the school. “Because of this, we know we achieved herd immunity at the school.”
Get the whole story.